Literature DB >> 22013995

Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression.

Elizabeth E Romero-Lanman1, Svetlana Pavlovic, Bhishma Amlani, Yvette Chin, Robert Benezra.   

Abstract

Understanding the mechanism by which embryonic stem (ES) cells self-renew is crucial for the realization of their therapeutic potential. Earlier, overexpression of Id proteins was shown to be sufficient to maintain mouse ES cells in a self-renewing state even in the absence of serum. Here, we use ES cells derived from Id deficient mice to investigate the requirement for Id proteins in maintaining ES cell self-renewal. We find that Id1(-/-) ES cells have a defect in self-renewal and a propensity to differentiate. We observe that chronic or acute loss of Id1 leads to a down-regulation of Nanog, a critical regulator of self-renewal. In addition, in the absence of Id1, ES cells express elevated levels of Brachyury, a marker of mesendoderm differentiation. We find that loss of both Nanog and Id1 is required for the up-regulation of Brachyury, and ectopic Nanog expression in Id1(-/-) ES cells rescues the self-renewal defect, indicating that Nanog is the major downstream target of Id1. These results identify Id1 as a critical factor in the maintenance of ES cell self-renewal and suggest a plausible mechanism for its control of lineage commitment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22013995     DOI: 10.1089/scd.2011.0428

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  36 in total

Review 1.  ZRF1: a novel epigenetic regulator of stem cell identity and cancer.

Authors:  Luigi Aloia; Santiago Demajo; Luciano Di Croce
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Reviewing and updating the major molecular markers for stem cells.

Authors:  Raquel Calloni; Elvira Alicia Aparicio Cordero; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

3.  Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.

Authors:  Jayanta K Das; Quentin Felty
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

4.  Inhibition of transforming growth factor β signaling promotes epiblast formation in mouse embryos.

Authors:  Sabitri Ghimire; Björn Heindryckx; Margot Van der Jeught; Jitesh Neupane; Thomas O'Leary; Sylvie Lierman; Winnok H De Vos; Susana Chuva de Sousa Lopes; Tom Deroo; Petra De Sutter
Journal:  Stem Cells Dev       Date:  2014-10-29       Impact factor: 3.272

Review 5.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness.

Authors:  Anna Lasorella; Robert Benezra; Antonio Iavarone
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

6.  TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

Authors:  Marko Stankic; Svetlana Pavlovic; Yvette Chin; Edi Brogi; David Padua; Larry Norton; Joan Massagué; Robert Benezra
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

7.  BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence.

Authors:  Yohei Hayashi; Edward C Hsiao; Salma Sami; Mariselle Lancero; Christopher R Schlieve; Trieu Nguyen; Koyori Yano; Ayako Nagahashi; Makoto Ikeya; Yoshihisa Matsumoto; Ken Nishimura; Aya Fukuda; Koji Hisatake; Kiichiro Tomoda; Isao Asaka; Junya Toguchida; Bruce R Conklin; Shinya Yamanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-28       Impact factor: 11.205

8.  Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.

Authors:  Hye-Yeong Jo; Youngsun Lee; Hongryul Ahn; Hyeong-Jun Han; Ara Kwon; Bo-Young Kim; Hye-Yeong Ha; Sang Cheol Kim; Jung-Hyun Kim; Yong-Ou Kim; Sun Kim; Soo Kyung Koo; Mi-Hyun Park
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

9.  TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.

Authors:  Jun Fu; Qun-ying Yang; Ke Sai; Fu-rong Chen; Jesse C S Pang; Ho-keung Ng; Aij-lie Kwan; Zhong-ping Chen
Journal:  Neuro Oncol       Date:  2013-07-21       Impact factor: 12.300

10.  Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.

Authors:  Haitao Wang; Carter Lindborg; Vitali Lounev; Jung-Hoon Kim; Ruth McCarrick-Walmsley; Meiqi Xu; Laura Mangiavini; Jay C Groppe; Eileen M Shore; Ernestina Schipani; Frederick S Kaplan; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2016-04-20       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.